Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Dow, Nasdaq Futures Drop Over 400 Points as Tech Retreats
08:56am, Friday, 15'th May 2026
Dow and Nasdaq futures have plunged over 400 points as investors suffer from a cooling tech sector and U.S.-China policy fatigue
DexCom, Inc. (DXCM) Analyst/Investor Day Transcript
10:00pm, Thursday, 14'th May 2026
DexCom, Inc. (DXCM) Analyst/Investor Day Transcript
Dexcom to appoint two directors, revamp board committee with Elliott
05:41pm, Thursday, 14'th May 2026
Medical device maker DexCom said on Thursday it has agreed with activist investor Elliott Investment Management to add two independent directors to the company's board and revamp a key board com
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
04:02pm, Thursday, 14'th May 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced key updates to its governance structure in conjunction with its upcoming 2026 Investor Day presentation that outlines a strategic
Pre-Market Stock Futures: The futures are trading lower on Tuesday, but another week and another set of new highs for the S&P 500 and the Nasdaq, as AI fever overshadowed Iran's peace counteroffer dis
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
03:43pm, Tuesday, 05'th May 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
3 Reasons Analysts Love DexCom
12:25pm, Tuesday, 05'th May 2026
While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a crucial component of a broader set of tools to address type 2 diabetes. With a
Dexcom to Host Investor Day on May 14, 2026
08:30am, Tuesday, 05'th May 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14, 2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise
11:00am, Friday, 01'st May 2026
DXCM stock jumps on Q1 beat as revenues rise 15% and margins expand, with strong CGM demand and raised profitability outlook boosting momentum.
DexCom Inc (DXCM) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Market Expansions
02:18am, Friday, 01'st May 2026
Revenue: $1.19 billion, up 15% from Q1 2025.US Revenue: $832 million, up 11% from Q1 2025.International Revenue: $360 million, up 26% from Q1 2025.Gross Profit
DexCom, Inc. (DXCM) Q1 2026 Earnings Call Transcript
09:51pm, Thursday, 30'th Apr 2026
DexCom, Inc. (DXCM) Q1 2026 Earnings Call Transcript
DexCom (DXCM) Q1 Earnings and Revenues Top Estimates
06:15pm, Thursday, 30'th Apr 2026
DexCom (DXCM) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.32 per share a year ago.
Dexcom reaffirms full-year forecast after topping quarterly estimates
04:52pm, Thursday, 30'th Apr 2026
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for quarterly results, helped by strong demand for its continuous glucose monit
Dexcom Reports First Quarter 2026 Financial Results
04:02pm, Thursday, 30'th Apr 2026
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports First Quarter 2026 Financial Results.
DXCM or MASI: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 29'th Apr 2026
Investors looking for stocks in the Medical - Instruments sector might want to consider either DexCom (DXCM) or Masimo (MASI). But which of these two stocks presents investors with the better value op
